Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 41 to 50 of 270 resources

  • Hepatitis C Commissioning Toolkit
    The Hepatitis C Commissioning Toolkit, an update to the original toolkit published in September 2013, sets out key commissioning responsibilities, with the intention of bringing clarity to an often highly fragmented commissioning landscape. The toolkit is also intended to aide commissioners in commissioning cost-effective services which are tailored to the needs of people with hepatitis C, by setting out how to ensure a clear, connected and properly funded hepatitis C care pathway, as well as providing good practice examples.
    England Case study, Tools & Templates, Strategy & Planning PDF
  • Drug-related infectious diseases in Europe
    This report provides an update on infectious diseases related to drug use in Europe for the period up to June 2016. It covers the most recent data both on infectious diseases among people who inject drugs in Europe, collected with the European Monitoring Centre for Drugs and Drug Addiction Drug-related infectious diseases (DRID) indicator, and on the responses in the area. It includes highlights and new findings discussed during the DRID indicator’s annual expert meeting, held in Lisbon on 6–8 June 2016.
    Rest of World Reports & Research PDF
  • The lived experience of interferon-free treatments for hepatitis C: A thematic analysis
    This research paper, published in the International Journal of Drug Policy, examines how interferon-free treatments for hepatitis C are being understood and experienced by patients.
    UK Reports & Research PDF
  • BBV Bulletin: Quarterly update report of the introduction of opt-out BBV testing in prisons from PHE, NHS England and NOMS
    This bulletin provides an update on the introduction of opt-out BBV testing in prisons across England. It provides an overview of results and findings from the 'phase 2 pathfinder' prisons, as well as a range of recommendations including for prison healthcare teams to work more closely with local ODNs to improve uptake and completion of hepatitis C treatment.
    England Nov 2016 Reports & Research PDF
  • Good practice case study: ROADS @ Bristol Drugs Project
    This HCV Action good practice case study looks at the work done by ROADS (Recovery Orientated Alcohol & Drugs Service) @ Bristol Drugs Project. When ROADS took over the service in November 2013, under 12% of clients assessed as appropriate to be tested for hepatitis C went on to actually be tested. Bristol ROADS made a concerted effort to increase the number of people receiving hepatitis C tests by better coordinating services and finding ways to address the complications that prevented people who had agreed to be tested for hepatitis C from actually receiving the test.
    UK, South West Case study PDF
  • Global report on access to hepatitis C treatment - Focus on overcoming barriers
    This is the first-ever global report on treatment access to hepatitis C medicines. The report provides the information that countries and health authorities need to identify the appropriate HCV treatment, and procure it at affordable prices. The report uses the experience of several pioneering countries to demonstrate how barriers to treatment access can be overcome.

    Rest of World Oct 2016 Reports & Research PDF
  • Laboratory reports of hepatitis C: April to June 2016
    This report from Public Health England provides statistics on the number of hepatitis A and hepatitis C laboratory reports in England and Wales from April to June 2016.
    England, Wales Reports & Research PDF
  • Pathways Coordinator Q&A
    Andy Pearson, The Hepatitis C Trust’s Pathways Coordinator, explains the role and the importance of testing and referral pathways for hepatitis C in substance misuse services.
    UK Other, Training PDF
  • Good practice case study: Community pharmacy testing on the Isle of Wight
    This HCV Action good practice case study looks at a community pharmacy testing pilot on the Isle of Wight. It involved the delivery of blood borne virus testing at 22 community pharmacies from September 2014 - May 2015. Primarily focused on increasing the numbers of people tested and diagnosed for hepatitis C, it trebled the number of tests carried out in community open access settings, and led to a significant increase in the numbers of people being referred to specialist care.

    This case study looks at why the pilot was established, how it operated, and the outcomes that it achieved.
    UK, South West Oct 2016 Case study PDF
  • EASL Recommendations on Treatment of Hepatitis C 2016
    These EASL Recommendations on Treatment of Hepatitis C are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the current optimal management of patients with acute and chronic HCV infections. These recommendations apply to therapies that have been approved by the European Medicines Agency and other national European agencies at the time of their publication.
    Rest of World Sep 2016 Other, Reports & Research PDF

Pages